Insider Shareholders with Direct Ownership of Rhythm Pharmaceuticals, Inc. (RYTM)
This section provides a comprehensive overview of the insiders with direct ownership of Rhythm Pharmaceuticals, Inc. (RYTM). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
RHYTHM PHARMACEUTICALS, INC. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
David P Meeker
President and CEO |
158,500 | 64,029 | 201,281 $10.3 Million | 9 |
Feb 19, 2025
Reduced 4.69%
|
Hunter C Smith
Chief Financial Officer |
168,263 | 87,969 | 109,929 $5.61 Million | 37 |
Feb 19, 2025
Reduced 1.98%
|
Yann Mazabraud
EVP, Head of International |
52,220 | 32,585 | 40,370 $2.06 Million | 14 |
Feb 16, 2025
Added 11.99%
|
Pamela J. Cramer
Chief Human Resources Officer |
119,695 | 102,975 | 19,209 $980,235 | 32 |
Feb 19, 2025
Reduced 4.86%
|
Joseph Shulman
Chief Technical Officer |
199,296 | 190,747 | 8,509 $434,214 | 39 |
Feb 19, 2025
Reduced 12.61%
|
William T. Roberts
Chief Accounting Officer |
7,313 | 2,894 | 7,872 $401,708 | 6 |
Mar 29, 2023
Reduced 10.38%
|
Jennifer Chien
EVP, Head of North America |
167,972 | 163,088 | 5,858 $298,933 | 42 |
Feb 19, 2025
Reduced 25.78%
|
Camille L Bedrosian
Director |
3,000 | 0 | 3,000 $153,090 | 1 |
Jun 21, 2024
Added 50.0%
|
3,000 | 0 | 3,000 $153,090 | 1 |
Jun 21, 2024
Added 50.0%
|
|
Stuart A Arbuckle
Director |
3,000 | 0 | 3,000 $153,090 | 1 |
Jun 21, 2024
Added 50.0%
|
Jennifer L Good
Director |
86,500 | 83,500 | 3,000 $153,090 | 7 |
Sep 17, 2024
Reduced 91.37%
|
David W J Mcgirr
Director |
3,000 | 0 | 3,000 $153,090 | 1 |
Jun 21, 2024
Added 50.0%
|
Lynn A. Tetrault
Director |
38,000 | 35,000 | 3,000 $153,090 | 9 |
Sep 10, 2024
Reduced 10.45%
|
Christophe Jean
Director |
3,000 | 0 | 3,000 $153,090 | 1 |
Jun 21, 2024
Added 50.0%
|
Christopher Paul German
Corporate Controller & CAO |
2,970 | 1,003 | 2,070 $105,632 | 4 |
Feb 19, 2025
Reduced 23.48%
|